Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.5B | 21.8B | 14.4B | 18.4B |
Cost of revenue | 13.6B | 19.3B | 11.8B | 15.8B |
Gross profit | 3.0B | 2.6B | 2.6B | 2.6B |
Operating expense | ||||
Research & development | 706.0M | 1.0B | 648.2M | 735.2M |
Selling general and admin | 824.6M | -5.7B | 2.3B | -290.9M |
Other operating expenses | 80.9M | 4.1B | -133.4M | 317.4M |
Operating income | 1.5B | 430.5M | 1.0B | 991.1M |
Non operating interest income | ||||
Income | 13.9M | 36.6M | 53.3M | 19.1M |
Expense | 16.9M | 39.6M | 14.5M | 14.2M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 744.0M | 1.0B | 966.4M |
Tax provision | 181.9M | 223.0M | 75.6M | 143.3M |
Net income | 1.2B | 521.1M | 957.9M | 823.2M |
Basic EPS | 0.4 | — | — | — |
Diluted EPS | 0.4 | — | — | — |
Basic average shares | 3.1B | — | — | — |
Diluted average shares | 3.1B | — | — | — |
EBITDA | 1.5B | 2.0B | 1.1B | 850.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | -74.2M | -223.7M | -24.6M | -37.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |